Jove
Visualize
Contact Us

Related Experiment Videos

The year's new drugs.

Ann I Graul, J R Prous

    Drug News & Perspectives
    |March 22, 2006
    PubMed
    Summary
    This summary is machine-generated.

    In 2005, 41 new biological drugs and diagnostic agents were launched. The United States led new product introductions, with anti-infectives and central nervous system drugs being highly active therapeutic areas.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The Year's New Drugs & Biologics - 2009.

    Drug news & perspectives·2010
    Same author

    Overcoming the obstacles in the pharma/biotech industry: 2009 update.

    Drug news & perspectives·2010
    Same author

    The year's new drugs & biologics - 2008.

    Drug news & perspectives·2009
    Same author

    Promoting, improving and accelerating the drug development and approval processes.

    Drug news & perspectives·2009
    Same author

    Overcoming the obstacles in the pharma/biotech industry: 2008 update.

    Drug news & perspectives·2009
    Same author

    The year's new drugs and biologics--2007.

    Drug news & perspectives·2008
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies

    Area of Science:

    • Pharmaceuticals and Drug Development
    • Biotechnology
    • Market Analysis

    Background:

    • The pharmaceutical industry continuously innovates, introducing new biological drugs and diagnostic agents.
    • Market dynamics and therapeutic trends influence the launch of novel medical products.

    Purpose of the Study:

    • To analyze the landscape of new biological drugs and diagnostic agents launched in 2005.
    • To identify the leading therapeutic areas and geographical markets for these new introductions.

    Main Methods:

    • Data collection on new market introductions in 2005.
    • Categorization of products by therapeutic group and market.

    Main Results:

    • Forty-one new biological drugs and diagnostic agents reached their first markets in 2005.

    Related Experiment Videos

  • Anti-infective therapy, immunomodulators, agents for immunization, and central nervous system drugs were the most active therapeutic groups, each with six market introductions.
  • The United States was the most active market, with 21 new launches, representing 50% of the total.

    • Conclusions:

    • The year 2005 saw significant activity in the launch of new biological drugs and diagnostic agents.
    • Key therapeutic areas and the United States market dominated new product introductions.